Insight

Sterility is one of the most critical quality attributes for parenteral preparations, injectables, biopharmaceuticals and numerous other pharmaceutical products. Sterilizing filtration removes viable microorganisms and particulate matter from liquids or gases to achieve a sterile state. A wide range of key factors must be taken into account when selecting sterilizing-grade filters, particularly the construction materials and their compatibility with process fluids. Validation is an indispensable component to guarantee the sterility of final drug products manufactured under aseptic conditions. The primary objective of sterilizing filter validation is to demonstrate and document the efficacy of the filtration process in achieving and maintaining sterility. Validation comprises multiple tests and assessments to verify the reliability, efficiency and consistent performance of filters in contaminant removal.

The core purpose of sterilizing filtration is to eliminate all viable microorganisms (excluding viruses) present in bulk drug solutions. Material compatibility with process fluids stands as a core consideration for filter selection. Process-related parameters shall also be evaluated, including process volume, flow rate, differential pressure, temperature and chemical properties of the feed solution.

Raw materials for sterilizing filters are subject to rigorous screening and control to comply with applicable quality standards and regulatory requirements. All filter materials shall be non-toxic and meet the criteria of USP Class VI and other toxicological specifications. Additionally, filters must not contain extractables that may alter or contaminate process fluids. Strict control over raw material sourcing, manufacturing equipment and production environment hygiene is required to prevent cross-contamination during filter production. Appropriate filter supports shall be selected to maximize product yield and ensure stable, efficient filtration operations.

Filtration efficiency against microorganisms is the paramount criterion. An ideal sterilizing-grade filter shall completely remove microorganisms from fluids without compromising product quality. For bacterial retention, filters with a nominal pore size of 0.2 μm or 0.22 μm are commonly adopted. While these two nominal values are used interchangeably by different manufacturers, the critical prerequisite is verified bacterial retention performance. For mycoplasma removal, filters with smaller pore sizes (0.1 μm or even 0.03 μm) are required, depending on manufacturer specifications and validation data.

After determining the required pore size rating and filter type, fluid characteristics shall be analyzed to identify the optimal filtration solution. Filtration processes vary significantly for simple aqueous solutions, high-viscosity high-concentration monoclonal antibody formulations and complex lipid nanoparticle preparations, each presenting distinct technical challenges. Some manufacturers provide single-membrane sterilizing filters, while others offer dual-membrane designs — either with two layers of identical pore size, or a pre-layer with larger pores upstream of the final sterilizing membrane.

The chemical composition of process fluids dictates the selection of membrane materials. Polyethersulfone (PES) is widely regarded as the preferred material for aqueous solutions due to its superior flow rate and high dirt-holding capacity.

Single-membrane filters are sufficient for feed solutions with low particulate load and low bioburden. For high-risk applications requiring enhanced sterility assurance, dual-membrane filters with identical pore sizes deliver an extra safety margin. For fluids with low particulate content but high bioburden, composite dual-membrane filters (0.45 μm pre-filter combined with 0.22 μm sterilizing membrane) can effectively extend the service life of the final sterilizing layer. Where process fluids carry high levels of particulates, pre-filters with high holding capacity shall be installed upstream of the final sterilizing filter.

Other influencing factors include required flow rate, batch volume and expected filter service life. For processes with low flow rates and small batch sizes, the difference among filter types is negligible; however, filter selection exerts a substantial impact on large-scale production. Single-membrane filters generally deliver the maximum flow rate per cartridge, yet they are prone to premature clogging and shortened service life for certain fluid matrices.

Non-destructive integrity testing verifies adequate bacterial retention capability of filters. A definitive correlation exists between bacterial retention and non-destructive integrity test results. Common integrity test methods for liquid-phase sterilizing filters include bubble point test, forward flow test, diffusion flow test and pressure hold test, with selection based on practical applicability for specific processes.

Filter selection must be tailored to the characteristics of the drug product and full process workflow. Contamination risks progressively increase from upstream processing through downstream operations to final filling. Filters with appropriate specifications and dimensions shall be incorporated into the validation protocol. Any process modification or product formulation revision necessitates re-validation of the sterilizing filtration system to confirm continued compliance with product and process requirements.

Validation shall confirm that defined sterilization procedures (supported by standard operating procedures, laboratory controls and repeatability tests) will not cause damage to filters prior to their use in aseptic processing. Different filter configurations adopt distinct sterilization methods: capsule filters are typically sterilized via gamma irradiation or autoclaving, while cartridge filter assemblies commonly undergo in-situ steam sterilization (SIP). The process steam must be free of particulates such as dust and pipeline scale, which would accelerate filter degradation.

The filter structure must remain intact throughout the filtration process. Interactions between filter materials and process fluids may alter fluid properties including temperature, pH and physical appearance. Relevant process data shall be collected and statistically analyzed to validate that filters do not adversely affect process fluids or disrupt production operations.

This study evaluates whether product-contact surfaces of filters bind any formulation components and cause product loss. Filters must not retain active pharmaceutical ingredients, excipients, carriers, diluents, proteins, preservatives or other formulation constituents. Adsorption analysis is performed during quality verification to quantify substance binding and ensure no significant product retention on filter media.

The filter system shall withstand all physical stresses encountered during production. Extreme temperature, hydraulic pressure and chemical exposure may lead to structural deformation, dissolution or rupture of filters. Full quality verification is required to confirm that all product-contact components (including filter membranes, support layers, cartridges, O-rings and auxiliary parts) can endure all sterilization and production conditions. Biocompatibility and biosafety are also mandatory evaluation items for pharmaceutical-grade filters.

Extractables and leachables testing is a critical validation item for sterilizing filters, which identifies, quantifies and assesses filter-derived physical and chemical contaminants migrating into process fluids. Extractables refer to substances extracted from polymeric or elastomeric materials under exaggerated solvent conditions, whereas leachables denote compounds migrating into drug products under routine process conditions. Non-volatile residue (NVR) testing is routinely used to quantify such contaminants. Risk assessment shall be conducted for all identified compounds to ensure no negative impact on final drug products.

Bacterial challenge testing verifies the filter’s capability to produce sterile filtrate. Under controlled process conditions, filters are challenged with a minimum of 10⁷ colony-forming units (CFU) of Brevundimonas diminuta (ATCC 19146) per square centimeter of membrane area. A valid test result confirming sterile effluent is the most universally accepted method for sterilizing filter validation, as this challenge test simultaneously assesses physicochemical interactions between filter media and liquid products under actual process conditions.